Search results
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
Investopedia· 3 days agoNovavax (NVAX) shares more than doubled in intraday trading Friday after announcing a $1.2 billion...
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Investor's Business Daily· 2 days agoNovavax shares shot more than 125% higher Friday on news of a Covid-19 vaccine licensing agreement...
Novavax’s 146% Surge Delivers ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg· 2 days agoHave a confidential tip for our reporters? Novavax Inc.’s record one-day gain is forcing some short...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
NBC 17 Raleigh· 3 days agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, has entered into a co-exclusive licensing agreement with Sanofi ...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg· 3 days agoHave a confidential tip for our reporters? Novavax Inc. shares surged after the company signed a...
Shah Capital urges Novavax shareholders to vote against three directors By Reuters
Investing.com· 6 days agoThe hedge fund had previously said it planned to put forward two of its own candidates for Novavax's...
Alight, Novavax, and More Stocks See Action From Activist Investors
Barrons.com· 2 days agoStarboard Value reached a cooperation agreement with Alight, a provider of cloud-based human capital...
Novavax's Top Shareholder Shah Capital Ramps up Efforts for Board Shakeup
US News & World Report· 6 days agoShah Capital, which currently owns a near 7.5% stake in Novavax and is its third-largest shareholder, reiterated that the company was "undervalued and continues to suffer ...
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Investor's Business Daily· 2 days agoNovavax will receive as much as $1.2 billion as part of a Covid vaccine licensing deal with Sanofi.
French, US drug firms team up for Covid-flu shot
Medical Xpress· 2 days agoFrench pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a COVID vaccine and develop another that combines...